Shenzhen Neptunus Bioengineering: Special note by the Board of Directors on matters covered by the unqualified audit opinion with emphasis in the 2023 Internal Control Audit Report

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.